一般社団法人 日本薬剤疫学会

すべての人々により安全な医薬品を

Japanese Society for Pharmacoepidemiology

 The Japanese Society for Pharmacoepidemiology (JSPE) is an academic organization headquartered in Tokyo with the number of its permanent membership exceeding 500, and dedicated to the advancement of pharmacoepidemiology. Since it was founded at the society’s inaugural academic general meeting in December 1995, JSPE plays a crucial role in promoting high-quality research on the safety and efficacy of pharmaceuticals. It is committed to enhancing the risk management of medications, including minimizing risks, and fosters international collaborations and exchanges with stakeholders across the globe.   

Through its activities, JSPE aims to contribute significantly to the development of pharmacoepidemiology, ensuring the safe and effective use of pharmaceuticals in healthcare. 

President:

Hisashi Urushihara, Dr.PH, Professor 
(Division of Drug Development & Regulatory Science Faculty of Pharmacy, Keio University ) 

Office: 

5th Floor, Gakkai Center Bdg. 
2-4-16 Yayoi, Bunkyo-ku, Tokyo, 113-0032 Japan

Phone/Fax: 

+81-3-5802-8603,

History: 

Founded in 1995, since then 
the Conference has been held every year.

Current Member: 

approximately 570, includes physician, 
pharmacist, epidemiologist and statistician. 

Publication: 

Japanese Journal of Pharmacoepidemiology 
(in Japanese), biannual publication, since 1996

16th Asian Conference on Pharmacoepidemiology and 29th Japanese Conference on Pharmacoepidemiology joint meeting 

Date: 

October 12-14, 2024

Chair: 

Nobuhiro Ooba, PhD
Professor, Deparment of Pharmacoepidemiology 
School of Pharmacy, Nihon University

Venue: 

The University of Tokyo Yasuda Auditorium / Ito International Research Center

Address: 

7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8654, Japan

Secretary General: 

Hiraku Kumamaru, MD, ScD 
Associate Professor, Department of Healthcare Quality Assessment 
The University of Tokyo Graduate School of Medicine 

E-mail: 

JSPE Updates

Sep,2023 


The results of a survey of databases applicable to clinical epidemiology and pharmacoepidemiology in Japan

Nov,2022 


The results of 2022 survey of databases applicable to clinical epidemiology and pharmacoepidemiology in Japan have been incorporated in “Database list & search site”

Aug,2021 


Ethics in clinical researches, and history and current status of research ethics in Japan: Invited talk from Japan at the international symposium in Korea in June 2021

Nov.2020


Joint statement to consolidate the pharmacovigilance systems for securing safety of the COVID-19 vaccine products issued by Japanese Society for Pharmacoepidemiology, Japanese Epidemiological Association, Society for Clinical Epidemiology, and The Japanese Society for Vaccinology

Mar,2003 


Provisional translation of the report of the working group on “Future Postmarketing Surveillance  in Japan” is presented.